Treatment of Acute Hemoptysis by Bronchial Artery Embolization with the Liquid Embolic Agent Ethylene Vinyl Alcohol Copolymer

Ayx, Isabelle; Müller-Wille, René; Wohlgemuth, Walter A.; Pfeifer, Michael; Lepiorz, Marc; Hubauer, H.; Goessmann, Holger; Stroszczynski, Christian; Zorger, N.

doi:10.1016/j.jvir.2016.12.1226

Cited by 16 publications

(9 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The inflated Scepter balloon created a "plug" and allowed for more controlled and deeper penetration into distal bronchial artery with indwelling coils without the need of robust forward flow, which is required in the much harder to control NBCA (Urbano et al 2014). While typically reserved for neurointervention (Linfante and Wakhloo 2007), there have been a few reports of the utility of Onyx in BAE (Ao et al 2013;Bommart et al 2012;Adamus Nürnberg et al 2010;Khalil et al 2010;Ayx et al 2017) with low recurrence rates for hemoptysis after embolization. Additionally, BAE with Onyx has few adverse reactions and patients have reported a high tolerance (Adamus Nürnberg et al 2010;Khalil et al 2010).…”

Section: Discussionmentioning

confidence: 99%

Recurrent massive hemoptysis in a patient with cystic fibrosis: balloon assisted Onyx embolization after bronchial artery coil recanalization

2021

View full text Add to dashboard Cite

Background Although not standard of care, Cystic Fibrosis patients with recurrent hemoptysis occasionally have coil embolization of bronchial arteries. In the event of recanalization of these arteries in this specific subset of patients, the presence of indwelling coils makes the prospect of conventional particle embolization more difficult, preventing both adequate catheterization of the coiled segment and reflux of the particles. Case presentation In this report, we describe a case of bronchial artery embolization of a complex Cystic Fibrosis patient with massive hemoptysis from recanalized coiled bronchial arteries utilizing a Scepter Balloon Catheter® (Microvention Terumo, USA) in administration of the liquid embolic agent Onyx® (Medtronic, USA). Conclusions The Scepter occlusion balloon catheter allowed for careful placement of the tip within the interstices of the pre-existing coils, allowing for Onyx injection directly into the coil mass without reflux, reconfirming the benefits of Onyx embolization in bronchial artery embolization and providing evidence that the Scepter occlusion balloon catheter should be added to the armamentarium of devices used in complex bronchial artery embolization for Cystic Fibrosis patients with massive hemoptysis.

show abstract

Section: Discussionmentioning

confidence: 99%

Recurrent massive hemoptysis in a patient with cystic fibrosis: balloon assisted Onyx embolization after bronchial artery coil recanalization

2021

View full text Add to dashboard Cite

show abstract

“…Non-adhesive, high-viscous polymers dissolved in dimethyl sulfoxide (DMSO) include tantalum powder or iodine component to enhance visibility and contrast [ 1 , 34 ] in cases of refractory massive haemoptysis in patients with CF where conventional particle embolisation has failed [ 35 ]. However, similar to NBCA, application of liquid polymers requires experience, and aggregation of the polymer may block the MC as well.…”

Section: Treatmentmentioning

confidence: 99%

CIRSE Standards of Practice on Bronchial Artery Embolisation

Kettenbach

Ittrich

Gaubert

et al. 2022

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

show abstract

“…The occlusion obtained is permanent. EVOH has been found effective and safe for treating cerebral arteriovenous malformations, type II endoleaks, hemoptysis, renal angiomyolipomas, and for peripheral hemostasis (11)(12)(13)(14)(15)(16)(17). When used for PVE, EVOH seemed to result in faster growth of FLR compared to other embolic agents (18).…”

Section: Original Articlementioning

confidence: 99%

Portal vein embolization with ethylene-vinyl alcohol copolymer for contralateral lobe hypertrophy before liver resection: safety, feasibility and initial experience

Gautier¹,

Chevallier²,

Mastier³

et al. 2021

Quant Imaging Med Surg

View full text Add to dashboard Cite

Background: To report our preliminary experience with preoperative portal vein embolization (PVE) using liquid ethylene vinyl alcohol (EVOH) copolymer.Methods: Retrospectively review of patients with primary or secondary liver malignancies scheduled for extensive hepatectomy after the induction of future liver remnant (FLR) hypertrophy by right or left PVE with EVOH as the only embolic agent between 2014 and 2018 at two academic centers. Cross-sectional imaging liver volumetry data obtained before and 3-6 weeks after PVE were used to assess the FLR volume (FLRV) increase, degree of FLR hypertrophy and the FLR kinetic growth rate (KGR).Results: Twenty-six patients (17 males; mean age, 58.7±11 years; range, 32-79 years) were included. The technical and clinical success rate was 100%. PVE produced adequate FLR hypertrophy in all patients.Embolization occurred in all targeted portal branches and in no non-target vessels. The %FLRV increased by 52.9%±32.5% and the degree of FLR hypertrophy was 16.7%±6.8%. The KGR was 4.4%±2.0% per week. Four patients experience minor complications after PVE which resolved with symptomatic treatment.The resection rate was 84.5%. One patient died during surgery for reasons unrelated to PVE.

show abstract

Treatment of Acute Hemoptysis by Bronchial Artery Embolization with the Liquid Embolic Agent Ethylene Vinyl Alcohol Copolymer

Cited by 16 publications

References 14 publications

Recurrent massive hemoptysis in a patient with cystic fibrosis: balloon assisted Onyx embolization after bronchial artery coil recanalization

Recurrent massive hemoptysis in a patient with cystic fibrosis: balloon assisted Onyx embolization after bronchial artery coil recanalization

CIRSE Standards of Practice on Bronchial Artery Embolisation

Portal vein embolization with ethylene-vinyl alcohol copolymer for contralateral lobe hypertrophy before liver resection: safety, feasibility and initial experience

Contact Info

Product

Resources

About